Trotter C L, McVernon J, Andrews N J, Burrage M, Ramsay M E
Immunisation Division, Communicable Disease Surveillance Centre, Health Protection Agency, 61 Colindale Avenue, NW9 5EQ, London, UK.
Lancet. 2003 May 3;361(9368):1523-4. doi: 10.1016/s0140-6736(03)13172-8.
Since 1999, the number of cases of Haemophilus influenzae type b (Hib) disease in the UK has risen. We investigated the role of population immunity in this change by testing more than 2600 serum samples from children aged 1-15 years. After the introduction of the routine Hib conjugate vaccination programme for infants, median antibody titres rose significantly in 1-year-olds. Individuals who received their first dose of vaccine at age 1-4 years in the original catch-up campaign initially had much higher concentrations of antibody than those who had been immunised in infancy. A second catch-up campaign in children aged 6 months to 4 years should be highly effective in boosting immunity and reducing disease in the short term.
自1999年以来,英国b型流感嗜血杆菌(Hib)疾病的病例数有所上升。我们通过检测2600多名1至15岁儿童的血清样本,调查了群体免疫在这一变化中的作用。在为婴儿引入常规Hib结合疫苗接种计划后,1岁儿童的抗体滴度中位数显著上升。在最初的补种活动中,1至4岁首次接种疫苗的个体最初的抗体浓度比婴儿期接种疫苗的个体高得多。对6个月至4岁儿童开展的第二次补种活动在短期内提高免疫力和减少疾病方面应该会非常有效。